Escuela de doctorado
FISIOPATOLOGÍA Y FARMACOLOGÍA
Publicacións (63) Publicacións nas que participase algún/ha investigador/a
2019
-
Fluoxetine oral treatment discloses 5-HT 1D receptor as vagoinhibitor of the cardiac cholinergic neurotransmission in rat
Canadian Journal of Physiology and Pharmacology, Vol. 97, Núm. 2, pp. 90-98
-
Hypertension exhibits 5-HT 4 receptor as a modulator of sympathetic neurotransmission in the rat mesenteric vasculature
Hypertension Research, Vol. 42, Núm. 5, pp. 618-627
-
Angiogenic response in an in vitro model of dog microvascular endothelial cells stimulated with antigenic extracts from Dirofilaria immitis adult worms
Parasites and Vectors, Vol. 12, Núm. 1
-
Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses
The Lancet, Vol. 393, Núm. 10174, pp. 899-909
-
Asthma diagnosis in infants and preschool children: a systematic review of clinical guidelines
Allergologia et Immunopathologia, Vol. 47, Núm. 2, pp. 107-121
-
Autologous mesenchymal stromal cells embedded in tricalcium phosphate for posterolateral spinal fusion: Results of a prospective phase I/II clinical trial with long-term follow-up
Stem Cell Research and Therapy, Vol. 10, Núm. 1
-
Barley-ß-glucans reduce systemic inflammation, renal injury and aortic calcification through ADAM17 and neutral-sphingomyelinase2 inhibition
Scientific Reports, Vol. 9, Núm. 1
-
Biopiracy versus One-World Medicine–From colonial relicts to global collaborative concepts
Phytomedicine, Vol. 53, pp. 319-331
-
Cardiotrophin-1 opposes renal fibrosis in mice: Potential prevention of chronic kidney disease
Acta Physiologica, Vol. 226, Núm. 2
-
Causes of hOCT1-Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor-Selective Gene Therapy
Hepatology, Vol. 70, Núm. 4, pp. 1246-1261
-
Chemosensitization of hepatocellular carcinoma cells to sorafenib by β-caryophyllene oxide-induced inhibition of ABC export pumps
Archives of Toxicology, Vol. 93, Núm. 3, pp. 623-634
-
Cost-effective, safe, and personalized cell therapy for critical limb ischemia in type 2 diabetes mellitus
Frontiers in Immunology, Vol. 10, Núm. JUN
-
Deferasirox reduces oxidative DNA damage in bone marrow cells from myelodysplastic patients and improves their differentiation capacity
British Journal of Haematology, Vol. 187, Núm. 1, pp. 93-104
-
Development and characterization of mouse monoclonal antibodies to eight human complement components: Analysis of reactivity with orthologs of nine mammalian genera
Comparative Immunology, Microbiology and Infectious Diseases, Vol. 62, pp. 7-12
-
Diagnostic and prognostic biomarkers in cholangiocarcinoma
Liver International, Vol. 39, Núm. S1, pp. 108-122
-
Dihydropyrimidine-2-thiones as Eg5 inhibitors and L-type calcium channel blockers: Potential antitumour dual agents
MedChemComm, Vol. 10, Núm. 9, pp. 1589-1598
-
Dirofilaria immitis: A new potential pathogen for the endangered iberian lynx (Lynx pardinus)
International Journal of Applied Research in Veterinary Medicine, Vol. 17, Núm. 1, pp. 17-21
-
Dispositivos de inhalación en medicación inhalada
Protocolo diagnostico terapéutico pediatría, Vol. 2, pp. 51-64
-
Dual RNA-seq analysis provides new insights into interactions between Norway spruce and necrotrophic pathogen Heterobasidion annosum s.l.
BMC Plant Biology, Vol. 19, Núm. 1
-
Epigenetic events involved in organic cation transporter 1-dependent impaired response of hepatocellular carcinoma to sorafenib
British Journal of Pharmacology, Vol. 176, Núm. 6, pp. 787-800